Together, these findings indicate that CCL5 deficiency provides a protective effect in ADR-induced nephropathy by reducing albuminuria, glomerular sclerosis, podocyte loss, and foot process effacement, suggesting that CCL5 contributes to the progression of glomerular injury. This evidence concerns the gene CCL5 and glomerulosclerosis.